[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.54.109. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1976

The Safety of Long-Term Clindamycin Therapy for Acne

Author Affiliations

From the Division of Dermatology, Department of Medicine, Albany Medical Center, Albany, NY.

Arch Dermatol. 1976;112(1):53-54. doi:10.1001/archderm.1976.01630250025007
Abstract

• Sixty patients with severe pustular and cystic acne were treated for prolonged periods with clindamycin (150 mg to 300 mg daily). The average duration of therapy was five months, with 18 patients being treated for more than six months. Only two (3.4%) patients developed mild diarrhea, which was rapidly reversible on discontinuance of the drug. No other adverse reactions were observed. These data suggest that long-term, low-dose clindamycin therapy may be safe for severe pustular or cystic acne.

(Arch Dermatol 112:53-54, 1976)

×